中心静脈ライン市場2021: メーカー、地域（ヨーロッパ、アジア太平洋、北アメリカ、南アメリカ）、タイプとアプリケーション、2028年までの予測 (アップデート版あり)

このレポートには、最新の市場図、統計、データが含まれています

ライセンスを選択

概要
目次

中心静脈ラインの市場は、今後8年間で約X.X％のCAGRで成長すると推定されており、2021年のX.X百万米ドルから、2028年にはX.X百万米ドルに達するでしょう。
さまざまな種類の中心静脈ライン、下流の消費分野、および世界中のさまざまな地域や国の競争環境のほとんどのセグメント化された消費および販売データを提供することを目的として、このレポートは一次および二次の信頼できるソースからの最新の市場データを分析します。

レポートはまた、推進要因、抑制要因などの最新の市場のダイナミクス、および合併、買収、投資などの業界ニュースを追跡します。市場規模（価値と量）、市場シェア、種類別の成長率、アプリケーションを提供し、定性的手法と定量的手法の両方を組み合わせて、さまざまな地域または国でミクロおよびマクロの予測を行います。
レポートは、市場を理解し、それに応じて事業拡大のための戦略を立てるのに役立ちます。戦略分析では、マーケティングチャネルと市場のポジショニングから潜在的な成長戦略までの洞察を提供し、中心静脈ライン業界の新規参入者または既存の競合他社に詳細な分析を提供します。

メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Baihe Medical
Teleflex
Bard
SCW MEDICATH
Lepu Medical
B.Braun
TuoRen
Edwards Lifesciences
Cook Medical
Fornia
PUYI Medical

タイプによる市場細分化：
シングルルーメン
ダブルルーメン
トリプルルーメン
他の
アプリケーションによる市場細分化：
頸静脈
鎖骨下静脈
大腿静脈
他の

レポートにおける国レベルのセグメンテーション：
アメリカ
日本
インド
ドイツ
英国
フランス
イタリア
スペイン
ポーランド
ロシア
中国
インドネシア
タイ
フィリピン
マレーシア
シンガポール
ベトナム
ブラジル
サウジアラビア
アラブ首長国連邦
カタール
バーレーン

Table of Contents

1 Study Coverage
1.1 Central Venous Line Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Central Venous Line Market Size Growth Rate by Product
1.4.2 Single-lumen
1.4.3 Double-lumen
1.4.4 Triple-lumen
1.4.5 Other
1.5 Market by End User
1.5.1 Global Central Venous Line Market Size Growth Rate by End User
1.5.2 Jugular Vein
1.5.3 Subclavian Vein
1.5.4 Femoral Vein
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Central Venous Line Market Size
2.1.1 Global Central Venous Line Revenue 2015-2028
2.1.2 Global Central Venous Line Sales 2015-2028
2.2 Central Venous Line Growth Rate by Regions
2.2.1 Global Central Venous Line Sales by Regions
2.2.2 Global Central Venous Line Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Central Venous Line Sales by Manufacturers
3.1.1 Central Venous Line Sales by Manufacturers
3.1.2 Central Venous Line Sales Market Share by Manufacturers
3.1.3 Global Central Venous Line Market Concentration Ratio (CR5 and HHI)
3.2 Central Venous Line Revenue by Manufacturers
3.2.1 Central Venous Line Revenue by Manufacturers (2015-2020)
3.2.2 Central Venous Line Revenue Share by Manufacturers (2015-2020)
3.3 Central Venous Line Price by Manufacturers
3.4 Central Venous Line Manufacturing Base Distribution, Product Types
3.4.1 Central Venous Line Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Central Venous Line Product Type
3.4.3 Date of International Manufacturers Enter into Central Venous Line Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Central Venous Line Sales by Product
4.2 Global Central Venous Line Revenue by Product
4.3 Central Venous Line Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Central Venous Line Breakdown Data by End User

6 North America
6.1 North America Central Venous Line by Countries
6.1.1 North America Central Venous Line Sales by Countries
6.1.2 North America Central Venous Line Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Central Venous Line by Product
6.3 North America Central Venous Line by End User

7 Europe
7.1 Europe Central Venous Line by Countries
7.1.1 Europe Central Venous Line Sales by Countries
7.1.2 Europe Central Venous Line Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Central Venous Line by Product
7.3 Europe Central Venous Line by End User

8 Asia Pacific
8.1 Asia Pacific Central Venous Line by Countries
8.1.1 Asia Pacific Central Venous Line Sales by Countries
8.1.2 Asia Pacific Central Venous Line Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Central Venous Line by Product
8.3 Asia Pacific Central Venous Line by End User

9 Central & South America
9.1 Central & South America Central Venous Line by Countries
9.1.1 Central & South America Central Venous Line Sales by Countries
9.1.2 Central & South America Central Venous Line Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Central Venous Line by Product
9.3 Central & South America Central Venous Line by End User

10 Middle East and Africa
10.1 Middle East and Africa Central Venous Line by Countries
10.1.1 Middle East and Africa Central Venous Line Sales by Countries
10.1.2 Middle East and Africa Central Venous Line Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Central Venous Line by Product
10.3 Middle East and Africa Central Venous Line by End User

11 Company Profiles
11.1 Baihe Medical
11.1.1 Baihe Medical Company Details
11.1.2 Company Business Overview
11.1.3 Baihe Medical Central Venous Line Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baihe Medical Central Venous Line Products Offered
11.1.5 Baihe Medical Recent Development
11.2 Teleflex
11.2.1 Teleflex Company Details
11.2.2 Company Business Overview
11.2.3 Teleflex Central Venous Line Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Teleflex Central Venous Line Products Offered
11.2.5 Teleflex Recent Development
11.3 Bard
11.3.1 Bard Company Details
11.3.2 Company Business Overview
11.3.3 Bard Central Venous Line Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bard Central Venous Line Products Offered
11.3.5 Bard Recent Development
11.4 SCW MEDICATH
11.4.1 SCW MEDICATH Company Details
11.4.2 Company Business Overview
11.4.3 SCW MEDICATH Central Venous Line Sales, Revenue and Gross Margin (2015-2020)
11.4.4 SCW MEDICATH Central Venous Line Products Offered
11.4.5 SCW MEDICATH Recent Development
11.5 Lepu Medical
11.5.1 Lepu Medical Company Details
11.5.2 Company Business Overview
11.5.3 Lepu Medical Central Venous Line Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Lepu Medical Central Venous Line Products Offered
11.5.5 Lepu Medical Recent Development
11.6 B.Braun
11.6.1 B.Braun Company Details
11.6.2 Company Business Overview
11.6.3 B.Braun Central Venous Line Sales, Revenue and Gross Margin (2015-2020)
11.6.4 B.Braun Central Venous Line Products Offered
11.6.5 B.Braun Recent Development
11.7 TuoRen
11.7.1 TuoRen Company Details
11.7.2 Company Business Overview
11.7.3 TuoRen Central Venous Line Sales, Revenue and Gross Margin (2015-2020)
11.7.4 TuoRen Central Venous Line Products Offered
11.7.5 TuoRen Recent Development
11.8 Edwards Lifesciences
11.8.1 Edwards Lifesciences Company Details
11.8.2 Company Business Overview
11.8.3 Edwards Lifesciences Central Venous Line Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Edwards Lifesciences Central Venous Line Products Offered
11.8.5 Edwards Lifesciences Recent Development
11.9 Cook Medical
11.9.1 Cook Medical Company Details
11.9.2 Company Business Overview
11.9.3 Cook Medical Central Venous Line Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Cook Medical Central Venous Line Products Offered
11.9.5 Cook Medical Recent Development
11.10 Fornia
11.10.1 Fornia Company Details
11.10.2 Company Business Overview
11.10.3 Fornia Central Venous Line Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Fornia Central Venous Line Products Offered
11.10.5 Fornia Recent Development
11.11 PUYI Medical

12 Future Forecast
12.1 Central Venous Line Market Forecast by Regions
12.1.1 Global Central Venous Line Sales Forecast by Regions 2021-2028
12.1.2 Global Central Venous Line Revenue Forecast by Regions 2021-2028
12.2 Central Venous Line Market Forecast by Product
12.2.1 Global Central Venous Line Sales Forecast by Product 2021-2028
12.2.2 Global Central Venous Line Revenue Forecast by Product 2021-2028
12.3 Central Venous Line Market Forecast by End User
12.4 North America Central Venous Line Forecast
12.5 Europe Central Venous Line Forecast
12.6 Asia Pacific Central Venous Line Forecast
12.7 Central & South America Central Venous Line Forecast
12.8 Middle East and Africa Central Venous Line Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Central Venous Line Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer